BOT 1.19% 41.5¢ botanix pharmaceuticals ltd

FAQ, page-21

  1. 3,356 Posts.
    lightbulb Created with Sketch. 852
    I just want to note that some one in the other thread believes they worked out that we get 2.5% of Kaken sales.... based on this figure you've reported that = $5,250,000 per annum OR $1,312,500.00 per quarter! THIS IS WITHOUT KOREA SALES.

    If the next quarterly displays 1.3 in income - expect this to go north, very north! If Korea does the same or MORE than Japan then consider this figure to double - Let's say they get into China where the population is far greater than both those two countries combined, is it silly to think just based off licensing deals that we could bring in 20m a year? No one looking at this - all consumed by a 6 month delay
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
41.5¢
Change
-0.005(1.19%)
Mkt cap ! $751.1M
Open High Low Value Volume
41.5¢ 42.5¢ 40.0¢ $2.133M 5.181M

Buyers (Bids)

No. Vol. Price($)
2 51664 40.5¢
 

Sellers (Offers)

Price($) Vol. No.
41.5¢ 341870 4
View Market Depth
Last trade - 16.10pm 05/09/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.